TGM2 and acute myeloid leukemia: A total of 33 genes (ALDH1A1, ALDOC, BACE2, BATF3, CA9, CALD1, COL5A1, DR1, EGLN3, ELOB, HBP1, HK1, ID2, KRT14, LRP8, NOS1, NOS2, PDK3, PLOD2, PSMA2, PSMA7, PSMB6, PSMC1, PSMC4, PTGS1, RPS27A, SIAH2, SLC16A1, SORL1, TGM2, THBS1, TPD52, and UBA52) were identified to have a significant prognostic value in patients with AML (p < 0.05).